{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:48:32Z","timestamp":1790999312288,"version":"4.1.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.molmed.2011.02.005","type":"journal-article","created":{"date-parts":[[2011,6,8]],"date-time":"2011-06-08T18:21:00Z","timestamp":1307557260000},"page":"293-300","source":"Crossref","is-referenced-by-count":22,"title":["Impaired autophagy: a link between neurodegenerative diseases and progressive myoclonus epilepsies"],"prefix":"10.1016","volume":"17","author":[{"given":"Mira","family":"Polajnar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"\u017derovnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2011.02.005_bib0005","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1474-4422(05)70043-0","article-title":"Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects","volume":"4","author":"Shahwan","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.molmed.2011.02.005_bib0010","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/j.0013-9580.2004.17504.x","article-title":"The epidemiology of the comorbidity of epilepsy in the general population","volume":"45","author":"Gaitatzis","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.molmed.2011.02.005_bib0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1528-1167.2009.02117.x","article-title":"The autosomal recessively inherited progressive myoclonus epilepsies and their genes","volume":"50","author":"Ramachandran","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.molmed.2011.02.005_bib0020","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/3059","article-title":"Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice","volume":"20","author":"Pennacchio","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2011.02.005_bib0025","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/sj.ejhg.5201300","article-title":"Loss of lysosomal association of cystatin B proteins representing progressive myoclonus epilepsy EPM1, mutations","volume":"13","author":"Alakurtti","year":"2005","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2011.02.005_bib0030","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1523\/JNEUROSCI.0682-09.2009","article-title":"Cystatin B deficiency sensitizes neurons to oxidative stress in progressive myoclonus epilepsy EPM1","volume":"29","author":"Lehtinen","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molmed.2011.02.005_bib0035","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.tibs.2009.08.002","article-title":"Lafora disease: insights into neurodegeneration from plant metabolism","volume":"34","author":"Gentry","year":"2009","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.molmed.2011.02.005_bib0040","doi-asserted-by":"crossref","first-page":"6898","DOI":"10.1523\/JNEUROSCI.20-18-06898.2000","article-title":"Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons","volume":"20","author":"Koike","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molmed.2011.02.005_bib0045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1528-1167.2009.02441.x","article-title":"Unverricht-Lundborg disease (EPM1)","volume":"51","author":"Genton","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.molmed.2011.02.005_bib0050","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1528-1167.2008.01546.x","article-title":"Clinical picture of EPM1-Unverricht-Lundborg disease","volume":"49","author":"Kalviainen","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.molmed.2011.02.005_bib0055","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1528-1167.2007.01422.x","article-title":"Molecular background of EPM1-Unverricht-Lundborg disease","volume":"49","author":"Joensuu","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.molmed.2011.02.005_bib0060","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1212\/WNL.0b013e3181b3888b","article-title":"Motor cortex and thalamic atrophy in Unverricht-Lundborg disease: voxel-based morphometric study","volume":"73","author":"Koskenkorva","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.molmed.2011.02.005_bib0065","first-page":"342","article-title":"Identification of mutations in cystatin B, the gene responsible for the Unverricht-Lundborg type of progressive myoclonus epilepsy (EPM1)","volume":"60","author":"Lalioti","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2011.02.005_bib0070","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1126\/science.271.5256.1731","article-title":"Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1)","volume":"271","author":"Pennacchio","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.molmed.2011.02.005_bib0075","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/excr.2000.5085","article-title":"Nuclear localization of cystatin B, the cathepsin inhibitor implicated in myoclonus epilepsy (EPM1)","volume":"262","author":"Riccio","year":"2001","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.molmed.2011.02.005_bib0080","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1042\/BC20090163","article-title":"Intracellular aggregation of human stefin B: confocal and electron microscopy study","volume":"102","author":"Ceru","year":"2010","journal-title":"Biol. Cell"},{"key":"10.1016\/j.molmed.2011.02.005_bib0085","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.bbamcr.2007.08.007","article-title":"Cystatin B and its EPM1 mutants are polymeric and aggregate prone in vivo","volume":"1783","author":"Cipollini","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molmed.2011.02.005_bib0090","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1110\/ps.051609705","article-title":"In vitro study of stability and amyloid-fibril formation of two mutants of human stefin B (cystatin B) occurring in patients with EPM1","volume":"14","author":"Rabzelj","year":"2005","journal-title":"Protein Sci."},{"key":"10.1016\/j.molmed.2011.02.005_bib0095","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.mehy.2004.11.038","article-title":"Protein aggregation as a possible cause for pathology in a subset of familial Unverricht-Lundborg disease","volume":"64","author":"Ceru","year":"2005","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.molmed.2011.02.005_bib0100","doi-asserted-by":"crossref","first-page":"15069","DOI":"10.1073\/pnas.1008818107","article-title":"Missense mutations in dystrophin that trigger muscular dystrophy decrease protein stability and lead to cross-beta aggregates","volume":"107","author":"Singh","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2011.02.005_bib0105","first-page":"727","article-title":"Lysosomal cysteine proteases and their protein inhibitors: recent developments","volume":"55","author":"Turk","year":"2008","journal-title":"Acta Chim. Slov."},{"key":"10.1016\/j.molmed.2011.02.005_bib0110","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0065-2571(01)00034-6","article-title":"Lysosomal cathepsins: structure, role in antigen processing and presentation, and cancer","volume":"42","author":"Turk","year":"2002","journal-title":"Adv. Enzyme Regul."},{"key":"10.1016\/j.molmed.2011.02.005_bib0115","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1093\/hmg\/11.23.2941","article-title":"New insights into the molecular basis of progressive myoclonus epilepsy: a multiprotein complex with cystatin B","volume":"11","author":"Di Giaimo","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2011.02.005_bib0120","doi-asserted-by":"crossref","first-page":"10078","DOI":"10.1074\/jbc.M109.034793","article-title":"Stefin B interacts with histones and cathepsin L in the nucleus","volume":"285","author":"Ceru","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2011.02.005_bib0125","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.febslet.2005.03.002","article-title":"Sensitization of stefin B-deficient thymocytes towards staurosporin-induced apoptosis is independent of cysteine cathepsins","volume":"579","author":"Kopitar-Jerala","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.molmed.2011.02.005_bib0130","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1038\/cdd.2010.29","article-title":"Cystatin B inhibition of TRAIL-induced apoptosis is associated with the protection of FLIP(L) from degradation by the E3 ligase itch in human melanoma cells","volume":"17","author":"Yang","year":"2010","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.molmed.2011.02.005_bib0135","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ajhg.2008.10.003","article-title":"A homozygous mutation in human PRICKLE1 causes an autosomal-recessive progressive myoclonus epilepsy-ataxia syndrome","volume":"83","author":"Bassuk","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2011.02.005_bib0140","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/brain\/awh377","article-title":"A new clinical and molecular form of Unverricht-Lundborg disease localized by homozygosity mapping","volume":"128","author":"Berkovic","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.molmed.2011.02.005_bib0145","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ana.21765","article-title":"SCARB2 mutations in progressive myoclonus epilepsy (PME) without renal failure","volume":"66","author":"Dibbens","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molmed.2011.02.005_bib0150","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1093\/oxfordjournals.hmg.a018916","article-title":"Laforin, defective in the progressive myoclonus epilepsy of Lafora type, is a dual-specificity phosphatase associated with polyribosomes","volume":"9","author":"Ganesh","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2011.02.005_bib0155","doi-asserted-by":"crossref","first-page":"30412","DOI":"10.1074\/jbc.M606117200","article-title":"Laforin, a dual specificity phosphatase that dephosphorylates complex carbohydrates","volume":"281","author":"Worby","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2011.02.005_bib0160","doi-asserted-by":"crossref","first-page":"8501","DOI":"10.1073\/pnas.0503285102","article-title":"Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin","volume":"102","author":"Gentry","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2011.02.005_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10038-005-0321-1","article-title":"Recent advances in the molecular basis of Lafora's progressive myoclonus epilepsy","volume":"51","author":"Ganesh","year":"2006","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.molmed.2011.02.005_bib0170","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1091\/mbc.E10-03-0227","article-title":"The laforin-malin complex, involved in Lafora disease, promotes the incorporation of K63-linked ubiquitin chains into AMP-activated protein kinase beta subunits","volume":"21","author":"Moreno","year":"2010","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.molmed.2011.02.005_bib0175","doi-asserted-by":"crossref","first-page":"19262","DOI":"10.1073\/pnas.0707952104","article-title":"Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo","volume":"104","author":"Tagliabracci","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2011.02.005_bib0180","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1093\/hmg\/ddi306","article-title":"Novel glycogen synthase kinase 3 and ubiquitination pathways in progressive myoclonus epilepsy","volume":"14","author":"Lohi","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2011.02.005_bib0185","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1074\/jbc.M708712200","article-title":"Malin decreases glycogen accumulation by promoting the degradation of protein targeting to glycogen (PTG)","volume":"283","author":"Worby","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2011.02.005_bib0190","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/hmg\/ddm006","article-title":"Lafora disease proteins malin and laforin are recruited to aggresomes in response to proteasomal impairment","volume":"16","author":"Mittal","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2011.02.005_bib0195","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1093\/hmg\/ddq190","article-title":"Laforin, the most common protein mutated in Lafora disease, regulates autophagy","volume":"19","author":"Aguado","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2011.02.005_bib0200","doi-asserted-by":"crossref","first-page":"991","DOI":"10.4161\/auto.6.7.13308","article-title":"Impaired autophagy in Lafora disease","volume":"6","author":"Knecht","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.molmed.2011.02.005_bib0205","first-page":"1229","article-title":"Laforin in autophagy: a possible link between carbohydrate and protein in Lafora disease?","author":"Puri","year":"2009","journal-title":"Autophagy"},{"key":"10.1016\/j.molmed.2011.02.005_bib0210","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-1-4419-6448-9_5","article-title":"Huntington's disease","volume":"685","author":"Roze","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.molmed.2011.02.005_bib0215","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/B:SCAM.0000007124.19463.e5","article-title":"Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins","volume":"24","author":"Huang","year":"1998","journal-title":"Somat. Cell Mol. Genet."},{"key":"10.1016\/j.molmed.2011.02.005_bib0220","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0968-0004(98)01350-4","article-title":"Glutamine repeats and neurodegenerative diseases: molecular aspects","volume":"24","author":"Perutz","year":"1999","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.molmed.2011.02.005_bib0225","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/archneurol.2010.194","article-title":"Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study","volume":"67","author":"Alcalay","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.molmed.2011.02.005_bib0230","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0197-4580(02)00135-5","article-title":"Abeta42 generation is toxic to endothelial cells and inhibits eNOS function through an Akt\/GSK-3beta signaling-dependent mechanism","volume":"24","author":"Suhara","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.molmed.2011.02.005_bib0235","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1046\/j.1432-1033.2002.03024.x","article-title":"Amyloid-fibril formation Proposed mechanisms and relevance to conformational disease","volume":"269","author":"Zerovnik","year":"2002","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.molmed.2011.02.005_bib0240","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1111\/j.1742-4658.2007.05919.x","article-title":"Therapeutic approaches for prion and Alzheimer's diseases","volume":"274","author":"Wisniewski","year":"2007","journal-title":"FEBS J."},{"key":"10.1016\/j.molmed.2011.02.005_bib0245","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/msj.20156","article-title":"Vaccination as a therapeutic approach to Alzheimer's disease","volume":"77","author":"Wisniewski","year":"2010","journal-title":"Mt. Sinai J. Med."},{"key":"10.1016\/j.molmed.2011.02.005_bib0250","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3233\/JAD-2008-15208","article-title":"Drug development based on the metals hypothesis of Alzheimer's disease","volume":"15","author":"Bush","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.molmed.2011.02.005_bib0255","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2119\/2007-00100.Irvine","article-title":"Protein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseases","volume":"14","author":"Irvine","year":"2008","journal-title":"Mol. Med."},{"key":"10.1016\/j.molmed.2011.02.005_bib0260","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.molmed.2011.02.005_bib0265","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","article-title":"Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease","volume":"155","author":"Lue","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molmed.2011.02.005_bib0270","doi-asserted-by":"crossref","first-page":"20057","DOI":"10.1073\/pnas.0905529106","article-title":"Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice","volume":"106","author":"Rhein","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2011.02.005_bib0275","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1126\/science.1105681","article-title":"Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease","volume":"307","author":"Stokin","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.molmed.2011.02.005_bib0280","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.neurobiolaging.2003.12.027","article-title":"Alzheimer's amyloid beta-peptide (1-42): involvement of methionine residue 35 in the oxidative stress and neurotoxicity properties of this peptide","volume":"25","author":"Butterfield","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.molmed.2011.02.005_bib0285","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/418291a","article-title":"Neurodegenerative disease: amyloid pores from pathogenic mutations","volume":"418","author":"Lashuel","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2011.02.005_bib0290","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0962-8924(00)01852-3","article-title":"Aggresomes, inclusion bodies and protein aggregation","volume":"10","author":"Kopito","year":"2000","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.molmed.2011.02.005_bib0295","article-title":"Autophagosome formation and molecular mechanism of autophagy","author":"Tanida","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.molmed.2011.02.005_bib0300","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","article-title":"Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy","volume":"305","author":"Cuervo","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.molmed.2011.02.005_bib0305","first-page":"687","article-title":"Studies on cellular autophagocytosis. The formation of autophagic vacuoles in the liver after glucagon administration","volume":"53","author":"Arstila","year":"1968","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molmed.2011.02.005_bib0310","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000109761","article-title":"The role of autophagy in age-related neurodegeneration","volume":"16","author":"McCray","year":"2008","journal-title":"Neurosignals"},{"key":"10.1016\/j.molmed.2011.02.005_bib0315","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.bbadis.2008.10.002","article-title":"Autophagy and the ubiquitin-proteasome system: collaborators in neuroprotection","volume":"1782","author":"Nedelsky","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molmed.2011.02.005_bib0320","unstructured":"Chin, L.S. et al. (2010) Parkin-mediated ubiquitin signalling in aggresome formation and autophagy. Biochem. Soc. Trans. 38, 144\u2013149"},{"key":"10.1016\/j.molmed.2011.02.005_bib0325","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nn.2575","article-title":"Autophagy gone awry in neurodegenerative diseases","volume":"13","author":"Wong","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.molmed.2011.02.005_bib0330","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1091\/mbc.E08-09-0971","article-title":"Kinesin-14 family proteins HSET\/XCTK2 control spindle length by cross-linking and sliding microtubules","volume":"20","author":"Cai","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.molmed.2011.02.005_bib0335","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4161\/auto.3906","article-title":"Autophagy, mitochondria and cell death in lysosomal storage diseases","volume":"3","author":"Kiselyov","year":"2007","journal-title":"Autophagy"},{"key":"10.1016\/j.molmed.2011.02.005_bib0340","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/sj.emboj.7601623","article-title":"Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4","volume":"26","author":"Scherz-Shouval","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2011.02.005_bib0345","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1074\/jbc.M704704200","article-title":"Calcium homeostasis and mitochondrial dysfunction in striatal neurons of Huntington disease","volume":"283","author":"Lim","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"Suppl. 2","key":"10.1016\/j.molmed.2011.02.005_bib0350","doi-asserted-by":"crossref","first-page":"S176","DOI":"10.1016\/j.parkreldis.2008.04.026","article-title":"Molecular pathways of programmed cell death in experimental Parkinson's disease","volume":"14","author":"Vila","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.molmed.2011.02.005_bib0355","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.yjmcc.2009.02.021","article-title":"What is the mitochondrial permeability transition pore?","volume":"46","author":"Halestrap","year":"2009","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.molmed.2011.02.005_bib0360","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0002-9440(10)61253-9","article-title":"Participation of autophagy in storage of lysosomes in neurons from mouse models of neuronal ceroid-lipofuscinoses (Batten disease)","volume":"167","author":"Koike","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molmed.2011.02.005_bib0365","doi-asserted-by":"crossref","first-page":"e9819","DOI":"10.1371\/journal.pone.0009819","article-title":"Induction of autophagy by cystatin C: a mechanism that protects murine primary cortical neurons and neuronal cell lines","volume":"5","author":"Tizon","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2011.02.005_bib0455","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/bies.200900012","article-title":"The emerging role of cystatins in Alzheimer's disease","volume":"31","author":"Zerovnik","year":"2009","journal-title":"Bioessays"},{"key":"10.1016\/j.molmed.2011.02.005_bib0370","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00401-010-0738-2","article-title":"New neuropathological findings in Unverricht-Lundborg disease: neuronal intranuclear and cytoplasmic inclusions","volume":"121","author":"Cohen","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.molmed.2011.02.005_bib0375","doi-asserted-by":"crossref","first-page":"25372","DOI":"10.1074\/jbc.M110.148668","article-title":"Genetic depletion of the malin E3 ubiquitin ligase in mice leads to Lafora bodies and the accumulation of insoluble laforin","volume":"285","author":"Depaoli-Roach","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2011.02.005_bib0380","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/hmg\/ddn398","article-title":"The malin-laforin complex suppresses the cellular toxicity of misfolded proteins by promoting their degradation through the ubiquitin-proteasome system","volume":"18","author":"Garyali","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2011.02.005_bib0385","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1460-9568.2010.07500.x","article-title":"Autophagy, inflammation and neurodegenerative disease","volume":"33","author":"Alirezaei","year":"2011","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.molmed.2011.02.005_bib0395","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1091\/mbc.12.5.1393","article-title":"Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation","volume":"12","author":"Waelter","year":"2001","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.molmed.2011.02.005_bib0400","doi-asserted-by":"crossref","unstructured":"Mizushima, N. et al. (2010) Methods in mammalian autophagy research. Cell 140, 313\u2013326","DOI":"10.1016\/j.cell.2010.01.028"},{"key":"10.1016\/j.molmed.2011.02.005_bib0405","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/cbic.200900666","article-title":"Strategies for the inhibition of protein aggregation in human diseases","volume":"11","author":"Bartolini","year":"2010","journal-title":"Chembiochem"},{"key":"10.1016\/j.molmed.2011.02.005_bib0410","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/0-387-23226-5_18","article-title":"Amyloid inhibitors and beta-sheet breakers","volume":"38","author":"Soto","year":"2005","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.molmed.2011.02.005_bib0415","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0092-8674(00)00117-3","article-title":"TOR, a central controller of cell growth","volume":"103","author":"Schmelzle","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2011.02.005_bib0420","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/cr.2010.82","article-title":"Overview of macroautophagy regulation in mammalian cells","volume":"20","author":"Mehrpour","year":"2010","journal-title":"Cell Res."},{"key":"10.1016\/j.molmed.2011.02.005_bib0425","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/hmg\/ddi458","article-title":"Rapamycin alleviates toxicity of different aggregate-prone proteins","volume":"15","author":"Berger","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2011.02.005_bib0430","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng1362","article-title":"Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease","volume":"36","author":"Ravikumar","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2011.02.005_bib0390","doi-asserted-by":"crossref","first-page":"620","DOI":"10.4161\/auto.4898","article-title":"Small molecule enhancers of rapamycin-induced TOR inhibition promote autophagy, reduce toxicity in Huntington's disease models and enhance killing of mycobacteria by macrophages","volume":"3","author":"Floto","year":"2007","journal-title":"Autophagy"},{"key":"10.1016\/j.molmed.2011.02.005_bib0435","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jnen\/64.2.113","article-title":"Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study","volume":"64","author":"Nixon","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.molmed.2011.02.005_bib0440","first-page":"25","article-title":"Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease","volume":"12","author":"Anglade","year":"1997","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.molmed.2011.02.005_bib0445","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.biocel.2004.04.014","article-title":"Autophagy is a part of ultrastructural synaptic pathology in Creutzfeldt-Jakob disease: a brain biopsy study","volume":"36","author":"Sikorska","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.molmed.2011.02.005_bib0450","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/ana.410420411","article-title":"Huntingtin localization in brains of normal and Huntington's disease patients","volume":"42","author":"Sapp","year":"1997","journal-title":"Ann. Neurol."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147149141100044X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147149141100044X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T10:38:55Z","timestamp":1560249535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147149141100044X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":91,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S147149141100044X"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2011.02.005","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}